The DOI matches its Crossref record; 115 of the 120 references it cites were found in a registry or an index; 45 of the 130 sources its claims cite were checked for support.
Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders
Open accessPublished version of a preprint
Abstract
Peripheral tissue metabolism of steroids (intracrinology) is now accepted as a key way in which tissues, such as the endometrium, can utilise inactive steroids present in the blood to respond to local physiological demands and ‘fine-tune’ the activation or inhibition of steroid hormone receptor-dependent processes. Expression of enzymes that play a critical role in the activation and inactivation of bioactive oestrogens (E1, E2) and androgens (A4, T, DHT), as well as expression of steroid hormone receptors, has been detected in endometrial tissues and cells recovered during the menstrual cycle. There is robust evidence that increased expression of aromatase is important for creating a local microenvironment that can support a pregnancy. Measurement of intra-tissue concentrations of steroids using liquid chromatography–tandem mass spectrometry has been important in advancing our understanding of a role for androgens in the endometrium, acting both as active ligands for the androgen receptor and as substrates for oestrogen biosynthesis. The emergence of intracrinology, associated with disordered expression of key enzymes such as aromatase, in the aetiology of common women’s health disorders such as endometriosis and endometrial cancer has prompted renewed interest in the development of drugs targeting these pathways, opening up new opportunities for targeted therapies and precision medicine.
Overview
CoChat Summary
TL;DR
This review argues that endometrial intracrinology—local activation and inactivation of oestrogens and androgens—is central to normal endometrial function and to disorders such as endometriosis and endometrial cancer. It synthesizes evidence on steroidogenic enzymes, receptor expression, LC-MS/MS tissue steroid measurements, and emerging intracrine-targeted therapies.
Key findings
- Local endometrial steroid concentrations can diverge from serum: LC-MS/MS studies found higher tissue oestrogens than in circulation and increased secretory-phase E2; intra-tissue DHEA was significantly higher than serum in secretory phase, whereas A4 and T were significantly lower in endometrial tissue than serum and not cycle-phase dependent.
- Endometriotic lesions show heterogeneous intracrine steroid production: in proliferative phase, E2 concentrations were approximately 3430 pg/mL in ovarian lesions (endometrioma) versus 238 pg/mL in peritoneal lesions; lesion testosterone exceeded blood, with elevated CYP11A1, CYP17A1 and HSD3B2, lower HSD17B2, and higher HSD17B6 and CYP19A1.
- In endometrial cancer, aromatase and 17βHSD1 expression correlated with poor prognosis; EC tissues had an 8-fold elevation in DHT versus normal endometrium; 5αR1 expression in 65% of samples positively correlated with histological grade, and women immunonegative for both AR and 5αR1 had poorer prognosis.
- Therapeutic targeting is advancing: intravaginal DHEA/prasterone showed local benefit without peripheral serum E2 changes; aromatase inhibitors are considered for postmenopausal endometriosis pain; AKR1C3 inhibitor BAY 1128688 completed phase I in 2016 with phase II underway; 17βHSD1 inhibitor FOR-6219 began phase Ia in July 2018; STS inhibitor STX64/Irosustat did not improve survival in a phase 2 endometrial cancer trial.
Methods
- Narrative review; PubMed and Scopus were searched on 4 May 2018 using terms including intracrinology, endometrium, aromatase, sulfatase and HSD. Reported counts included intracrinology 167 references in Scopus; intracrinology and endometrium 11 PubMed/21 Scopus; aromatase and endometrium 398; aromatase and endometrium and cancer and human 135; sulfatase and endometrium 84; HSD and endometrium 131.
- Evidence was synthesized from human endometrial tissues and cells, mouse models, LC-MS/MS steroid profiling, immunohistochemistry/qRT-PCR, in vitro decidualisation studies, and clinical trial reports; no formal systematic review or meta-analysis is described.
Limitations
- Stated in the paper: whole endometrial tissue homogenates cannot quantify contributions of specific cellular compartments; lesion types differ in local steroid concentrations and steroid-metabolising enzyme expression; no study has identified definitive de novo steroidogenesis from normal endometrial tissue; further studies are needed on cell cross-talk, non-coding RNAs, and therapeutic evaluation.
- Evident from the text: this is a narrative review with a non-systematic search limited to PubMed/Scopus on one date and no formal quality appraisal; many cited therapeutic findings are early-phase, awaited, or from cell/animal models.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Histology of the human endometrium during the normal cycle. Full-thickness endometrial biopsies from hysterectomy specimens stained with haematoxylin and eosin. (A) Proliferative phase: note the presence of long curving glands (G) and some stromal oedema [23]. (B) Secretory phase: note the prominent glands (G), which have a dilated lumen and an irregular outer border stretching down into the basal compartment [24]. In the luminal (functional layer) immune cells are readily detected (most of these are likely to be macrophages and uterine natural killer (uNK) cells [17,19]), as are areas of decidualised fibroblasts (DEC) close to arterioles.](https://figures.cochat.ai/paper-figures/5e773595523641bb91fdbbb026f2a065/endometrial-intracrinology-oestrogens-androgens-and-endometrial-disorders-figure-1.jpg)
![Figure 2 Expression of AKR1C3 in human endometrial stromal fibroblasts is increased in response to a decidualisation stimulus resulting in increased biosynthesis and secretion of testosterone. Based on a figure published in [43] under a CC-BY licence: concentrations of T were determined using an ELISA on days 4 or 8 of the experiment. Immunohistochemistry was determined on day 4 of experiment; AKR1C3 (red stain) Sytox Green nuclear stain (green), no primary antibody negative control (inset) (** p < 0.01).](https://figures.cochat.ai/paper-figures/34497bd770804c58a71cef28219442ed/endometrial-intracrinology-oestrogens-androgens-and-endometrial-disorders-figure-2.jpg)
![Figure 3 In vitro decidualisation of endometrial stromal fibroblasts results in upregulation of aromatase protein expression (green). Based on data reported in [13]. ESC—primary endometrial stromal fibroblasts; positive control (+) was a protein extract from human placenta, aromatase protein 58kDa. Nuclear counterstain DAPI (blue); Aromatase (green); B-Actin loading control (red).](https://figures.cochat.ai/paper-figures/6db870b0750849b3bbc006749bf3b14f/endometrial-intracrinology-oestrogens-androgens-and-endometrial-disorders-figure-3.jpg)
Verification
Claims the paper makes
38 Valid · 0 Not valid · 52 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Detailed immunohistochemical studies using fixed full-thickness endometrial tissues in combination with validated antibodies [27] have identified nuclear staining for AR, ERalpha and ERbeta in the human endometrium during the normal menstrual cycle [16,18,28,29].”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > 2. Endometrium—A Sex Hormone-Dependent Multicellular Tissue > 2.2. Expression of Androgen and Oestrogen Receptors in the Endometrium, Endometriosis and Endometrial Cancer
What the sources say
- Partly supportedcites [27] Saunders, 2000, Differential expression of estrogen receptor-α and -β and androgen receptor in the ovaries of marmosets and humans, Biol. Reprod. sourceExperimental — accuracy not yet measured
The Materials and Methods (pp. 1–2) describe validated receptor antibodies and fixed, paraffin-embedded ovarian tissue from women and marmosets. They do not describe full-thickness endometrial tissue, so the tissue specification attached to this citation is unsupported. The separate citations [16,18,28,29] are offered for the endometrial nuclear-staining finding. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [16] Critchley, 2009, Hormone receptor dynamics in a receptive human endometrium, Reprod. Sci. source
- Not checked — no full text of the sourcecites [18] Henderson, 2003, Steroid receptor expression in uterine natural killer cells, J. Clin. Endocrinol. Metab. source
- Partly supportedcites [28] Marshall, 2011, In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis, J. Clin. Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The Results (page unavailable) report AR immunoexpression in proliferative-phase endometrial stroma, and the Materials and Methods (page unavailable) state that stromal cells express ERα and ERβ. The copy does not establish nuclear staining for all three receptors in fixed full-thickness tissue across the normal menstrual cycle. The validated-antibodies phrase has a separate citation [27], so it is not assessed against this source. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [29] Critchley, 2001, Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium, J. Clin. Endocrinol. Metab. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Landmark studies in mice by the Bagchi group demonstrated that aromatase activity within the endometrium was essential for establishment of pregnancy in that species [49,50].”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > 4. Intracrine Steroid Biosynthesis in the Normal Endometrium > 4.3. Oestrogen Biosynthesis and Metabolism
What the sources say
- Supportedcites [49] Das, 2009, De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis, Proc. Natl. Acad. Sci. USA source
The Results section reports that inhibiting uterine aromatase in pregnant mice severely impaired implantation, reduced decidual mass, and led to resorption of most implanted embryos. The authors conclude that local aromatase activity is essential for endometrial functions supporting early pregnancy; the experiment used ovariectomized, progesterone-supplemented mice. (LLM, conf=0.91)
- Partly supportedcites [50] Das, 2012, Estrogen-induced expression of Fos-related antigen 1 (FRA-1) regulates uterine stromal differentiation and remodeling, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says that inhibiting uterine aromatase with letrozole inhibited decidualization and neovascularization in mice, supporting a role for local aromatase activity after embryo attachment. It does not establish that this activity is essential for pregnancy establishment as a whole; the paper distinguishes these post-attachment processes from preimplantation receptivity. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Strikingly, we have demonstrated that conditioned media from decidualised stromal cells increases uNK migration in an oestrogen-dependent manner.”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > 4. Intracrine Steroid Biosynthesis in the Normal Endometrium > 4.5. Intracrine and Paracrine Impact of Tissue Biosynthesis of Androgens and Oestrogens in Endometrium
What the sources say
- Partly supportedcites [57] Gibson, 2015, Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2, Hum. Reprod. sourceExperimental — accuracy not yet measured
The Results section ('Estrogens promote uNK cell motility'; page not provided) reports that direct treatment with E1 or E2 increased uNK migration and that an estrogen-receptor antagonist blocked the effect. The Methods section describes treating isolated uNK cells with estrogens, not conditioned media from decidualised stromal cells. The claimed effect of that conditioned media is therefore not established by this paper. (LLM, conf=0.87)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“There is robust evidence that increased expression of aromatase is important for creating a local microenvironment that can support a pregnancy.”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > Abstract
What the sources say
- Supportedcites [49] Das, 2009, De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis, Proc. Natl. Acad. Sci. USA source
The Results report increased aromatase expression in the decidua during early mouse pregnancy and show that inhibiting its activity impaired implantation and embryo development. The Discussion explains that locally produced estrogen promotes vascular development in the decidual tissue, supporting the claimed pregnancy-supportive local environment. (LLM, conf=0.90)
- Supportedcites [50] Das, 2012, Estrogen-induced expression of Fos-related antigen 1 (FRA-1) regulates uterine stromal differentiation and remodeling, J. Biol. Chem. source
The Discussion reports increased uterine P450 aromatase during early pregnancy in mice and says that blocking its activity inhibited decidualization and neovascularization. These findings support the claim that increased aromatase helps create a local uterine environment supportive of pregnancy, within the mouse setting studied. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Peripheral tissue metabolism of steroids (intracrinology) is now accepted as a key way in which tissues, such as the endometrium, can utilise inactive steroids present in the blood to respond to local physiological demands and ‘fine-tune’ the activation or inhibition of steroid hormone receptor-dependent processes.”
- Also stated in: § 1. What Do We Mean by ‘Intracrinology’? · plain
“Peripheral tissue metabolism of steroids is now accepted as a key way in which tissues such as the endometrium can respond to local physiological demands and ‘fine-tune’ the activation or inhibition of steroid hormone receptor-dependent processes.”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > Abstract
What the sources say
- Not checked — no full text of the sourcecites [3] Huhtinen, 2014, Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions, J. Clin. Endocrinol. Metab. source
- Not checked — no full text of the sourcecites [4] Huhtinen, 2012, Estrogen biosynthesis and signaling in endometriosis, Mol. Cell. Endocrinol. source
- Not checked — no full text of the sourcecites [5] Labrie, 2001, DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology, Front. Neuroendocrinol. source
- Supportedcites [6] Labrie, 2000, Intracrinology: Role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease, J. Mol. Endocrinol. source
The Abstract describes circulating inactive precursors being converted to active sex steroids in peripheral tissues and says those tissues adjust steroid formation and metabolism to local requirements. The section on 17-HSDs identifies the endometrium among human tissues with high estrogen-forming enzyme activity. Together, these passages support the sentence’s description of local fine-tuning of steroid action; page numbers are not available in our copy. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. What Do We Mean by ‘Intracrinology’? · plain
65 more claims · 17 with their cited sources checked
Create a free account to see all 101 claims and to verify the 9 references still open.
- It may state two separate claims as one. 31
Citations
Cites
Noyes, R. W., Hertig, A. T., & Rock, J. (1950) · Fertility and Sterility · doi:10.1016/s0015-0282(16)30062-0 · Cited by 2,843 · cited 1×
“(A) Proliferative phase: note the presence of long curving glands (G) and some stromal oedema [23].”
BackgroundEndometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940 · cited 2×
“Endometriosis can be associated with debilitating pelvic pain and in most but not all women, symptoms regress after menopause, with many of the drug regimens used to treat symptomatic endometriosis being based on suppression of ovarian cyclicity [64].”
BackgroundNatural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Burger, H. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02985-0 · Cited by 771 · cited 16×
“DHEA is produced by the adrenal glands and by the ovary and is abundant in the circulation.”
BackgroundInfluentialLabrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419 · cited 1×
“Sulfation is mediated by sulfotransferase enzymes and requires the action of 3′-phospho-adenosine-5′-phosphosulphate synthase (PAPSS) enzymes to provide a sulphate moiety for conjugation [53].”
BackgroundDalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., Morton, R. A., & Steiner, M. S. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0034-6 · Cited by 403 · cited 1×
“The pharmaceutical industries have developed a number of selective androgen receptor modulators to target AR in muscle as a therapy for age-related or cancer-related loss of muscle function [91,92].”
BackgroundLabrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366 · cited 1×
“However, in more recent studies and reviews, ‘intracrinology’ is now usually discussed on the basis that it is tissue-specific, local production (and inactivation) of sex steroids without significant release of active sex steroids into the peripheral circulation [1,5,6], with less attention being paid to the source an…”
BackgroundMenstrual physiology: implications for endometrial pathology and beyond
Maybin, J. A., & Critchley, H. O. D. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv038 · Cited by 337 · cited 1×
“It is notable that many authors have classified menstruation as an ‘inflammatory event’ highlighting increased concentrations of prostaglandins, which may also be generated by intracrine mechanisms, involving local enzyme expression, as well as increased synthesis of pro-inflammatory cytokines, chemokines and matrix m…”
Background
Cited by
Physiology of the Endometrium and Regulation of Menstruation
Critchley, H. O. D., Maybin, J. A., Armstrong, G. M., & Williams, A. R. W. (2020) · Physiological Reviews · doi:10.1152/physrev.00031.2019 · Cited by 536
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
Jain, V., Chodankar, R. R., Maybin, J. A., & Critchley, H. O. D. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00629-4 · Cited by 165
Wiwatpanit, T., Murphy, A. R., Lu, Z., Urbanek, M., Burdette, J. E., Woodruff, T. K., & Kim, J. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz100 · Cited by 135
Nola, R. D., Menga, A., Castegna, A., Loizzi, V., Ranieri, G., Cicinelli, E., & Cormio, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102401 · Cited by 103
Analysis of serum and endometrial progesterone in determining endometrial receptivity
Labarta, E., Sebastián-León, P., Devesa-Peiró, A., Celada, P., Vidal, C., Gilés, J., Rodríguez-Varela, C., Bosch, E., & Díaz-Gimeno, P. (2021) · Human Reproduction · doi:10.1093/humrep/deab184 · Cited by 96
Metadata
- Authors
- Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K.
- Affiliations
- Centre for Inflammation Research (GB)
- Corresponding author
- Saunders, Philippa T.K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-22
- Volume
- 19
- Issue
- 10
- Pages
- 3276
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6214123
- OpenAlex
- W2894914503
- Cited by
- 70
- References
- 120
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 10 · 2019: 6 · 2018: 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Medical Research Council (MR/N024524/1, MR/P00265X/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- steroid hormone metabolism, aromatase, estrogen, androgens, endometrium, menstrual cycle, androgen receptor, estrogen synthesis, endometriosis, endometrial cancer, steroid hormone receptors
- MeSH terms
- Androgens, Dehydroepiandrosterone, Endometrium, Estrogens, Female, Humans, Testosterone, Uterine Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders. https://app.cochat.ai/papers/10.3390/ijms19103276
- The paper
- Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2018). Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19103276
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.